MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings Current Ratio 2011-2026 | ONVO
Annual Current Ratio Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.52 | 2.31 | 4.08 | - | 15.6 | 10.3 | 10 | 10.8 | 14.2 | 10.8 | 26 | 1.93 | 0.72 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26 | 0.72 | 9.19 |
Quarterly Current Ratio Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.76 | 3.7 | 4.91 | 3.52 | 1.1 | 2.2 | 3.37 | 2.31 | 3.29 | 4.13 | 4.95 | 4.08 | 8.99 | 9.61 | 10.6 | 10.8 | 9.23 | 49.8 | - | 55.4 | - | - | - | 15.7 | 13.3 | 5.64 | 5.94 | 9.39 | 9.9 | 11.3 | 12.1 | 9.51 | 10.8 | 11.7 | 13.9 | 10.2 | 14.6 | 11.4 | 14.7 | 12.5 | 13.6 | 14.8 | 17.3 | 11.2 | 13.8 | 18.2 | 15.2 | 26.4 | 17.7 | 18.6 | 1.91 | 2.07 | 0.76 | 0.26 | 0.12 | 0.23 | 0.43 | 0.43 | 0.43 | 0.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.4 | 0.12 | 10 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
2.01 | $ 110.24 | -2.86 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Waters Corporation
WAT
|
2.02 | $ 289.16 | -3.79 % | $ 17.2 B | USA |
 |
Exagen
XGN
|
1.43 | $ 2.68 | -3.94 % | $ 57.8 M | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 16.36 | -11.57 % | $ 176 M |  China |
 |
Sotera Health Company
SHC
|
1.23 | $ 13.13 | -3.03 % | $ 3.73 B | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
1.76 | $ 62.25 | -5.81 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 23.53 | -4.74 % | $ 654 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 159.16 | -3.62 % | $ 7.89 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 195.51 | -1.33 % | $ 21.7 B | USA |
 |
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
0.87 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
2.51 | $ 8.7 | -4.92 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 264.2 | -1.56 % | $ 22 B | USA |
 |
Psychemedics Corporation
PMD
|
2.18 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
4.93 | $ 25.97 | -4.52 % | $ 33.7 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 16.78 | -3.95 % | $ 894 M | USA |
 |
Quotient Limited
QTNT
|
0.861 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
1.71 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | Britain |
 |
VolitionRx Limited
VNRX
|
0.265 | $ 0.2 | 1.87 % | $ 19.2 M |  Singapore |
 |
Bioventus
BVS
|
1.5 | $ 8.94 | -3.46 % | $ 596 M | USA |
 |
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Meridian Bioscience
VIVO
|
6.92 | - | - | $ 1.49 B | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 181.52 | -3.27 % | $ 129 B | USA |
 |
Surmodics
SRDX
|
2.99 | - | - | $ 608 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.35 | $ 4.29 | -6.54 % | $ 2.3 M | USA |